BRIDGEBIO PHARMA, INC.

Registrant on federal lobbying filings · filed 2025 to 2026

$0 Income reported

1 Clients represented

6 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $2,110,000 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. 1 filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the registrant's LDA id (401107898), not by name.

Clients 1

BRIDGEBIO PHARMA, INC. $2,110,000 6 filings

Lobbyists named 2

SCOTT HINKLE 1 filing · through 2026 Sr. Leg. Assistant and Counsel, Policy Dir. and Counsel, Leg. Dir. and Counsel, Deputy Chief of Staff (CoS)/Leg. Dir./Counsel, CoS and Counsel, DC CoS and Coun…
TRIPP ADAMS 1 filing · through 2026 Staff Assistant and Legislative Correspondent for Sen. Johnny Isakson; Legislative Correspondent for Sen. Kelly Loeffler; Health Research Assistant and Staff M…

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

Reported by year 2 years

2026 $920,000 2 filings
2025 $1,190,000 4 filings

Issues lobbied 1

Pharmacy 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 6
SENATE 6

Recent filings 7 total

Q2

BRIDGEBIO PHARMA, INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $500,000 expenses · posted Jul 20, 2026

View → 4A

BRIDGEBIO PHARMA, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $280,000 expenses · posted Jul 17, 2026

View → Q1

BRIDGEBIO PHARMA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $420,000 expenses · posted Apr 20, 2026

View → Q4

BRIDGEBIO PHARMA, INC. Amended

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $270,000 expenses · posted Jan 20, 2026

View → Q3

BRIDGEBIO PHARMA, INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $270,000 expenses · posted Oct 20, 2025

View → Q2

BRIDGEBIO PHARMA, INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $320,000 expenses · posted Jul 17, 2025

View → Q1

BRIDGEBIO PHARMA, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $320,000 expenses · posted Apr 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.